Free Trial

Mizuho Cuts Synopsys (NASDAQ:SNPS) Price Target to $600.00

Synopsys logo with Computer and Technology background

Key Points

  • Mizuho recently lowered its price target for Synopsys (NASDAQ:SNPS) from $700.00 to $600.00, maintaining an "outperform" rating, which indicates a potential upside of 38.44% from the current price.
  • Multiple analysts have adjusted their ratings on Synopsys, with Bank of America setting a target of $525.00 and some downgrading from "strong-buy" to "hold" or "underperform," illustrating a cautious outlook.
  • Synopsys shares have experienced significant trading activity, with the stock price rising by 11.8% recently. The current stock price is around $433.39, while it has a market capitalization of $67.24 billion.
  • Five stocks we like better than Synopsys.

Synopsys (NASDAQ:SNPS - Get Free Report) had its target price lowered by investment analysts at Mizuho from $700.00 to $600.00 in a report released on Thursday,Benzinga reports. The brokerage presently has an "outperform" rating on the semiconductor company's stock. Mizuho's price target suggests a potential upside of 38.44% from the stock's current price.

Several other equities research analysts also recently weighed in on SNPS. Bank of America reiterated an "underperform" rating and set a $525.00 target price (down previously from $625.00) on shares of Synopsys in a research note on Wednesday. Baird R W downgraded shares of Synopsys from a "strong-buy" rating to a "hold" rating in a research report on Wednesday. Wells Fargo & Company reduced their price target on shares of Synopsys from $630.00 to $550.00 and set an "equal weight" rating for the company in a research note on Wednesday. Stifel Nicolaus reduced their price target on shares of Synopsys from $650.00 to $550.00 and set a "buy" rating for the company in a research note on Wednesday. Finally, Citigroup lowered shares of Synopsys from a "neutral" rating to an "underperform" rating in a research note on Wednesday. Eleven investment analysts have rated the stock with a Buy rating, four have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $585.33.

Check Out Our Latest Stock Report on SNPS

Synopsys Stock Up 11.8%

NASDAQ:SNPS traded up $45.61 during trading hours on Thursday, hitting $433.39. The company's stock had a trading volume of 11,487,119 shares, compared to its average volume of 1,578,963. Synopsys has a 52-week low of $365.74 and a 52-week high of $651.73. The stock has a market capitalization of $67.24 billion, a P/E ratio of 34.02, a price-to-earnings-growth ratio of 3.97 and a beta of 1.14. The stock has a fifty day moving average of $594.99 and a 200-day moving average of $506.99. The company has a current ratio of 7.02, a quick ratio of 6.85 and a debt-to-equity ratio of 1.01.

Insider Buying and Selling

In related news, CEO Sassine Ghazi sold 11,366 shares of the business's stock in a transaction that occurred on Tuesday, September 2nd. The shares were sold at an average price of $589.01, for a total transaction of $6,694,687.66. Following the completion of the sale, the chief executive officer directly owned 71,615 shares of the company's stock, valued at $42,181,951.15. The trade was a 13.70% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CRO Richard S. Mahoney sold 9,010 shares of the company's stock in a transaction that occurred on Wednesday, June 18th. The shares were sold at an average price of $471.21, for a total transaction of $4,245,602.10. Following the completion of the sale, the executive directly owned 1,485 shares of the company's stock, valued at $699,746.85. The trade was a 85.85% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 24,031 shares of company stock valued at $13,168,999 over the last ninety days. Insiders own 0.62% of the company's stock.

Institutional Trading of Synopsys

A number of hedge funds have recently modified their holdings of SNPS. Centaurus Financial Inc. raised its stake in Synopsys by 22.5% in the 2nd quarter. Centaurus Financial Inc. now owns 1,334 shares of the semiconductor company's stock worth $684,000 after purchasing an additional 245 shares in the last quarter. Orion Porfolio Solutions LLC lifted its holdings in Synopsys by 1.2% during the 2nd quarter. Orion Porfolio Solutions LLC now owns 25,706 shares of the semiconductor company's stock worth $13,179,000 after buying an additional 307 shares during the period. Thrivent Financial for Lutherans lifted its holdings in Synopsys by 1.3% during the 2nd quarter. Thrivent Financial for Lutherans now owns 6,933 shares of the semiconductor company's stock worth $3,549,000 after buying an additional 90 shares during the period. MASTERINVEST Kapitalanlage GmbH acquired a new position in Synopsys during the 2nd quarter worth about $2,477,000. Finally, Stance Capital LLC acquired a new position in Synopsys during the 2nd quarter worth about $1,393,000. Institutional investors and hedge funds own 85.47% of the company's stock.

Synopsys Company Profile

(Get Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Further Reading

Analyst Recommendations for Synopsys (NASDAQ:SNPS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.